Andrew Stephens

Andrew Stephens has a diverse work experience spanning several companies and roles. Andrew began their career as a student/resident at the University of Colorado Health Sciences Center in 1983. Andrew then worked as a Senior Scientist at NeXagen from 1993 to 1996, followed by an Associate Director role at NeXstar/Gilead Science until 2001. From 2001 to 2003, they served as a Group Leader at Schering AG. Andrew then worked at OSI Pharmaceuticals as a Senior Director from 2003 to 2010. After that, they served as V.P. Experimental Medicine, Oncology/Diagnostic Imaging at Bayer HealthCare from 2010 to 2012. Andrew then joined Piramal Imaging as VP, Clinical Research and Development from 2012 to 2013, and subsequently became their Chief Medical Officer until 2018. Currently, they are working as the Chief Medical Officer at Life Molecular Imaging since 2018.

Andrew Stephens attended Graland from 1964 to 1973 and graduated. Andrew then studied at the University of Colorado Boulder from 1977 to 1980, earning a Bachelor's degree in Chemistry and Philosophy. From 1983 to 1989, they continued their education at the University of Colorado Anschutz Medical Campus, obtaining a MD and a Ph.D. in Biochemistry. Finally, from 1990 to 1993, they completed their medical education at the University of Colorado Anschutz Medical Campus, earning a Doctor of Medicine (M.D.) degree in Internal Medicine.